• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

"First, Do No Harm"-Trainees' Observation of Risk Reduction in the Treatment of Overactive Bladder.

作者信息

Bennett Alaina T, Ringel Nancy E, Menhaji Kimia, Brown Oluwateniola E, Hall Evelyn F, Cardenas-Trowers Olivia O, Falk Kerac N, Jeney Sarah E S, Barnes Hayley, Escobar Christina, Tellechea Laura M, Sappenfield Elisabeth C, Mehta Shailja, Chang Olivia H

机构信息

From the Division of Urogynecology, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR.

Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Medstar Washington Hospital Center and Georgetown University School of Medicine, Washington, DC.

出版信息

Female Pelvic Med Reconstr Surg. 2021 Jan 1;27(1):2-4. doi: 10.1097/SPV.0000000000000978.

DOI:10.1097/SPV.0000000000000978
PMID:33369964
Abstract
摘要

相似文献

1
"First, Do No Harm"-Trainees' Observation of Risk Reduction in the Treatment of Overactive Bladder.“首先，勿伤患者”——实习生对膀胱过度活动症治疗中风险降低的观察
Female Pelvic Med Reconstr Surg. 2021 Jan 1;27(1):2-4. doi: 10.1097/SPV.0000000000000978.
2
Drug therapy for an overactive bladder.膀胱过度活动症的药物治疗。
Womens Health (Lond). 2015 Jul;11(4):445-8. doi: 10.2217/whe.15.31. Epub 2015 Aug 4.
3
Combination of solifenacin and mirabegron for overactive bladder management.
BJU Int. 2015 Oct;116(4):498-9. doi: 10.1111/bju.13142.
4
Re: The efficacy and tolerability of the β3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients.回复：β3肾上腺素能受体激动剂米拉贝隆治疗老年患者膀胱过度活动症症状的疗效和耐受性
J Urol. 2015 Mar;193(3):947. doi: 10.1016/j.juro.2014.12.072. Epub 2014 Dec 18.
5
Words of Wisdom. Re: Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony).智慧之言。关于：米拉贝隆与索利那新联合治疗膀胱过度活动症患者：一项随机、双盲、剂量范围、2期研究（交响乐）的疗效和安全性结果
Eur Urol. 2015 Jun;67(6):1189-90. doi: 10.1016/j.eururo.2015.02.017.
6
[MIRABEGRON--A NEW DRUG FOR TREATMENT OF OVERACTIVE BLADDER].米拉贝隆——一种治疗膀胱过度活动症的新药
Urologiia. 2015 Jul-Aug(4):121-4.
7
[Developments in the medical treatment of overactive bladder].[膀胱过度活动症的医学治疗进展]
Semergen. 2016 Nov-Dec;42(8):557-565. doi: 10.1016/j.semerg.2015.10.006. Epub 2015 Dec 4.
8
[Value of mirabegron in the treatment of overactive bladder].米拉贝隆在治疗膀胱过度活动症中的价值
Urologe A. 2019 Apr;58(4):432-433. doi: 10.1007/s00120-019-0916-3.
9
Urinary incontinence: Patient-reported outcome measures favour use of mirabegron in patients with OAB.尿失禁：患者报告的结局指标支持在膀胱过度活动症患者中使用米拉贝隆。
Nat Rev Urol. 2015 Nov;12(11):593. doi: 10.1038/nrurol.2015.223. Epub 2015 Sep 8.
10
Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study.米拉贝隆与索利那新联合用药与单药治疗对膀胱过度活动症患者的长期安全性及疗效：SYNERGY II研究
Actas Urol Esp (Engl Ed). 2019 Jan-Feb;43(1):51-52. doi: 10.1016/j.acuro.2018.06.002. Epub 2018 Jul 17.